Investing.com - Pieris Pharmaceuticals (NASDAQ:PIRS) Inc reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Pieris Pharmaceuticals Inc announced earnings per share of $-0.130 on revenue of $5.37M. Analysts polled by Investing.com anticipated EPS of $-0.105 on revenue of $10.47M.
Pieris Pharmaceuticals Inc shares are down 25.34% from the beginning of the year, still down 77.43% from its 52 week high of $4.52 set on November 5, 2021.
Pieris Pharmaceuticals Inc follows other major Healthcare sector earnings this month
Pieris Pharmaceuticals Inc's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar